Telix Pharmaceuticals (ASX:TLX) will change its reporting currency to US dollars from Australian dollars, effective Jan. 1, according to a Tuesday Australian bourse filing.
The change allows the company to align to the predominant currency used for reporting revenue, costs, and corresponding cash flows, which are primarily generated in the US, the filing added.
The company will also convert the comparative periods in upcoming financial results to US dollars, per the filing.
The company's shares fell almost 1% in recent Tuesday trade but earlier hit an all-time high.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。